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The  use of hMSCs  for allogeneic  therapies  requiring  lot  sizes  of  billions  of  cells  will necessitate  large-scale
culture  techniques  such  as the  expansion  of cells  on microcarriers  in  bioreactors.  Whilst  much  research
investigating  hMSC  culture  on  microcarriers  has  focused  on growth,  much  less  involves  their  harvesting
for  passaging  or as a step  towards  cryopreservation  and  storage.  A successful  new  harvesting  method
has  recently  been  outlined  for cells  grown  on  SoloHill  microcarriers  in a 5  L  bioreactor  [1]. Here,  this  new
method  is set  out  in detail,  harvesting  being  deﬁned  as a two-step  process  involving  cell  ‘detachment’
from  the  microcarriers’  surface  followed  by  the  ‘separation’  of  the  two  entities.  The  new  detachment
method  is  based  on  theoretical  concepts  originally  developed  for secondary  nucleation  due  to  agitation.
Based  on this  theory,  it is  suggested  that  a short  period  (here  7  min)  of intense  agitation  in the  presence
of  a  suitable  enzyme  should  detach  the  cells  from  the  relatively  large  microcarriers.  In addition,  once
detached,  the  cells should  not  be  damaged  because  they  are  smaller  than  the Kolmogorov  microscale.
Detachment  was  then  successfully  achieved  for  hMSCs  from  two different  donors  using  microcarrier/cell
suspensions  up  to  100  mL  in  a  spinner  ﬂask.  In both  cases,  harvesting  was  completed  by  separating  cells
from  microcarriers  using  a Steriﬂip® vacuum  ﬁlter.  The  overall  harvesting  efﬁciency  was  >95% and  after
harvesting,  the cells  maintained  all the  attributes  expected  of hMSC  cells.  The  underlying  theoretical
concepts  suggest  that  the  method  is  scalable  and  this  aspect  is  discussed  too.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  Open access under CC BY license.. Introduction
Currently there is signiﬁcant emphasis on improving human
esenchymal stem cell (hMSC) expansion techniques due to the
nterest in these cells for treating a number of diseases/disorders
2]. Studies have taken place investigating the culture of hMSCs on a
ange of commercially available microcarriers including Cytodex-
 [3–5], Cytodex-3 [6–8], Cultispher-S [9–11], Cultispher-G [12],
oloHill Plastic P102-L [13] and Collagen [14].
The choice of microcarrier depends on several factors, including
ell attachment and proliferation, and whether they are xeno-
ree. However, in the majority of cultivation studies listed above,
here has been little focus on the harvesting procedure, or con-
ideration of the ability to effectively harvest should the process
ncrease in scale [15]. Yet, detachment or dissociation of cells from
he microcarrier surface and subsequent retention of cell quality
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E-mail  address: c.j.hewitt@lboro.ac.uk (C.J. Hewitt).
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ttp://dx.doi.org/10.1016/j.bej.2014.02.005
369-703X © 2014 The Authors. Published by Elsevier B.V. Open access under CC BY license.is equally as important as cell attachment and proliferation given
that the product of interest for cell therapies is the cell itself. It
is also important to recognise that, independent of whether the
cells are to be reused for further expansion following a passage or
stored prior to use for therapeutic or other purposes, harvesting
involves two steps. Firstly, the cells are detached from microcar-
riers to produce a cell–microcarrier suspension; and secondly, a
further separation step leaving the cells in suspension without the
microcarriers present. Therefore we  have employed the term ‘har-
vesting’ to denote this two step process of recovering the hMSCs
free from microcarriers. The term ‘detachment’ or ‘dissociation’ is
used just for the ﬁrst step of removing the cells from the micro-
carrier surface; and the second step is designated ‘separation’ and
involves the use of techniques such as ﬁltration or centrifugation.
These issues will only be exacerbated as expansion scale increases
and therefore it is crucial to consider cell harvesting strategies from
the outset so as to ensure a viable, complete bioprocess.Typically, cell detachment from microcarriers is by enzymatic
digestion [16]. Weber et al. (2007) [17] studied detachment using
different enzymes and a range of microcarriers (Biosilon, Cytodex
1, Cytodex 3, RapidCell and P102-L). They expanded hMSC-TERT
80 A.W. Nienow et al. / Biochemical Engin
Nomenclature
dmicrocarrier diameter of microcarrier
dE size of a small entity in suspension
D  agitator diameter
DM-I detachment parameter due to
microcarrier–impeller impacts
DM-M detachment parameter due to
microcarrier–microcarrier impacts
hefﬁciency harvesting efﬁciency
hactual number of viable cells obtained after harvesting
hexpected number of viable cells in culture
M mass of media
N  agitator speed
P  power
Po power number
Re  Reynolds number
T  bioreactor diameter
X  microcarrier concentration.
Greek  letters
εT local speciﬁc energy dissipation rate
ε¯T mean speciﬁc energy dissipation rate
 ˚  ˚ = εT max/ε¯T
K Kolmogorov turbulence microscale
 viscosity
 kinematic viscosity
L liquid density
Subscripts
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ells in spinner ﬂasks and then detached the cells exposing them to
ither trypsin, accutase, collagenase or a trypsin-accutase mixture
enerally for 6 min. The cells cultivated on Biosilon, RapidCell and
102-L were detached successfully, especially with the trypsin, and
rypsin-accutase mixture achieving high cell yield and viabilities
ear 100%. The results using collagenase were generally poor for
ytodex 1 and Cytodex 3 with any of the enzyme solutions where
ven after exposure for up to 10 min, signiﬁcant detachment of the
ells was not obtained. After another spinner ﬂask expansion and
arvest, the cells were successfully differentiated to adipocytes.
hough a very interesting paper, the scale at which the harvest-
ng was undertaken was only 5 mL,  very small compared to current
nd predicted future need.
Others have suggested that a non-enzymatic harvesting proce-
ure would be preferable so as to avoid potential cell damage or
hange in the immunophenotype of the cell [18,19]. Work by Yang
t al. [8] has highlighted the possibility of harvesting hMSCs with-
ut the need for enzymatic digestion by using a modiﬁed Cytodex-3
icrocarrier coated with a thermo responsive polymer. The hMSCs
ere expanded on these microcarriers, after which the culture tem-
erature was lowered to 32 ◦C where it was suggested that hMSCs
ere able to detach from the microcarriers. However, this method
nvolves an extra process step (coating of the microcarrier with the
olymer), which in effect makes the innate surface properties of a
icrocarrier redundant and may  prove problematic if a process has
een designed to take advantage of its original surface properties.
t may  also prove difﬁcult to obtain an even coating of the thermo
esponsive polymer across the entire surface of the microcarrier
specially on scale-up.
Enzyme-free dissociation buffers also exist but are rarely
eported to be used for routine passaging of cells and someeering Journal 85 (2014) 79–88
formulations may  not be suitable for use with hMSCs. Indeed,
one  study using a Gibco-brand enzyme-free dissociation buffer to
detach hMSCs grown on tissue culture plastic found that cell via-
bility following detachment was  signiﬁcantly reduced compared
to trypsin controls (∼70% compared to >90%, respectively) and
that cells also failed to reattach to tissue culture plastic [20].
In  a recently-published paper [1], we  have reported the success-
ful cultivation of hMSCs on Plastic 102-L microcarriers (SoloHill,
USA) in a 5 L bioreactor (2.5 L working volume) agitated at an
impeller speed, NJS (rev/s), just sufﬁcient to keep all the microcar-
riers in suspension. This microcarrier was  selected from a range
of commercially available and in-house produced microcarriers,
based initially on an assessment of the efﬁciency of cell proliferation
in microtitre plates [21]. It was  found that the Plastic P102-L with-
out any surface pre-treatment gave a level of attachment as good
as any other and better than Cytodex-1. A complimentary study in
spinner ﬂasks also showed similar relative levels of attachment to
the different microcarriers (data not shown) [21]. Given the desire
to choose a xeno-free microcarrier and not having special thermo-
responsive microcarriers available, it was  decided to choose Plastic
P102-L for this work. Successful cell harvesting (detachment plus
further cell–microcarrier separation) to allow for the recovery of
cells was reported [1]. However, as the main thrust of that paper
was to report in detail how the successful cultivation was under-
taken, the harvesting aspects of the work were not described in
detail.
Here, we concentrate mainly on the development of the detach-
ment step associated with the earlier study. Based on the above
analysis of the literature, there did not seem to be any reason to
choose as a starting point any detachment method other than that
recommended by the manufacturers, SoloHill, of the Plastic P102-L
[22]. This protocol involved exposure to trypsin-EDTA for 15 min;
but as set out below, it did not prove at all successful for primary
hMSC lines from two different donors. However, having cultured
the cells on Plastic P102-L beads, moving to surface-modiﬁed beads
[8] did not seem advisable and in addition, that approach did not
seem suitable for scale-up. Therefore, we  decided to try to develop
a new detachment method based on certain theoretical concepts
that would, unlike the technique proposed by SoloHill, be scalable
and reproducible. Here we  discuss how these concepts applied at
this relatively small scale should form a sound basis for scaling
up to commercial levels and describe the experiments and results
obtained, mentioned brieﬂy previously [1]. However, in order not
to repeat the precise details already reported concerning cultiva-
tion conditions in the spinner ﬂasks and the 5 L bioreactor from
which the microcarriers and attached cells were obtained for har-
vesting, the reader is referred to the previous paper [1]. Here, the
emphasis is entirely on the two cell harvesting steps applied to two
hMSC donor lines giving a technique which should be suitable for
scaling up to a full hMSC production process.
2. Theoretical basis for the new detachment protocol
Dos  Santos et al. [13] used TrypLE Express aided by intense agita-
tion (650 rpm) for 5–7 min  to speed up the separation of cells from a
microcarrier–cell suspension in a 0.5 mL  sample taken from a spin-
ner ﬂask culture in order to assess the number of live cells that had
been grown. It was decided to develop a larger scale protocol based
on using agitation to speed up the process. This approach is not an
obvious one as generally there is a concern that excessive agitation
damages cells, particularly animal cells because of the lack of a cell
wall [23]. However, it is also recognised that excessive exposure
to the types of enzymes used in detachment can cause processing
problems even when the cells are not themselves the product [24].
The amount of damage depends on the type and concentration of
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he enzyme and the time of exposure [8,19]. On the other hand,
here is increasing evidence that animal cells are less sensitive to
echanical stress than originally thought both with respect to cell
iability and density [25,26] and protein quality [25]. It was there-
ore decided to use trypsin-EDTA for detachment but to enhance it
y increased mechanical stress from agitation for a shorter time
han that suggested in the manufacturer’s protocol to minimise
amage to the cells whether from stress or enzymatic action.
.1.  Stresses on cells and microcarriers from agitation
There are a number of mechanisms that can give rise to mechan-
cal stress on microcarriers and the cells on them [23,27]. When
rowing cells, there are two issues, both of which can lead to a
eterioration in performance in the bioreactor; one aspect relates
o cell growth and/or viability and the other to cell quality. These
ssues are that the stress will detach the cells from the microcar-
iers and subsequently performance will be compromised; or the
tress will damage the cell whilst still on the microcarrrier. How-
ver, when detachment is desired, then providing a high stress for a
hort time to ensure the cells are detached but not directly damaged
ay represent an appropriate strategy.
.1.1. The impact of turbulent ﬂow
The most commonly addressed stress associated with agitation
s that arising from turbulence. In agitated bioreactors, provided
he Reynolds number, Re (=ND2/) is ≥2 × 104, the ﬂow is turbu-
ent. Under these conditions, Kolmogorov’s theory can be applied
o the ﬂow to establish the potential for damage to cells in suspen-
ion [28]. The theory has also been applied to cells on microcarriers.
owever, most published work in which mechanical stress issues
ith microcarriers have been addressed were carried out in spinner
asks or similar sized bioreactors with gentle agitation, just sufﬁ-
ient to maintain microcarriers in suspension, NJS which gave Re
alues just <2 × 104, i.e. just in the transition regime [6,27,29,30].
evertheless, for the want of any other approach, with microcar-
iers, it has always been assumed that Kolmogorov’s theory is still
pplicable under these transitional ﬂow conditions.
The application of Kolmogorov’s theory to ﬂuid dynamic stress
ue to turbulence on freely suspended cells is discussed in detail
lsewhere [23,31]. This theory suggests that provided the size of
he biological entity, dE, that is suspended in the ﬂow is less than
he Kolmogorov scale, K, then the entity should not be damaged
here
K =
(
3
εT max
)1/4
(1)
here  εTmax is the maximum local speciﬁc energy dissipation rate
lose to an impeller and  is the kinematic viscosity. The mean spe-
iﬁc energy dissipation rate, ε¯T , is numerically equal to the speciﬁc
ower, P/M where
¯ T =
P
M
= PoLN
3D5
M
(2)
here  Po is the impeller power number, D is the impeller diameter
nd M is the mass of medium and microcarriers in the vessel. In
ddition,
T max = ˚ε¯T (3)
here   ˚ depends on the impeller type and impeller diame-
er/vessel diameter ratio, D/T. It is also difﬁcult to determine
xperimentally and depends signiﬁcantly on the model used to
onvert raw turbulent ﬂow measurement whether laser-based [32]
r using hot-ﬁlm anemometry [33] into εTmax. Values of  ˚ from
bout 10 to greater than 100 have been reported with a trend toeering Journal 85 (2014) 79–88 81
smaller  values with large D/T ratios and vice versa [34]. A value
used for studies of a range of biological entities has been about
30 [35]. Alternatively, if  ˚ is unknown, εTmax can be estimated
by the long-standing recommendation [36], which is still consid-
ered appropriate [37], that all the energy dissipation occurs in the
impeller zone, of volume equal to the impeller swept volume. This
approach also implies that  ˚ increases with smaller D/T ratios.
Thus, provided the impeller power number is known, it is possible
to estimate the Kolmogorov scale.
This theory has been successfully applied to bacteria [38], yeast
[39] and animal cells [23]. However, for cells on microcarriers, per-
haps because the structure of the entity (cells on microcarriers) is
different or perhaps because of the Re number indicating ﬂow in the
transitional regime, it has been found that cell growth is not com-
promised if K ≥ ∼0.6dmicrocarrier [30]. Similar results were found by
Hewitt et al. [6] using the swept volume concept to estimate εTmax.
2.1.2. The effect of microcarrier impacts
Little work has been reported on the cell damage from micro-
carriers by impact with other microcarriers or with the rotating
impeller. On the other hand, much has been done in relation to
damage to crystals (the removal of tiny nuclei, a process known as
secondary nucleation, from the surface of relatively large crystals,
typical of the size of microcarriers) from such mechanisms [40].
Theories for the two cases of particle–particle impacts [41] and
particle–impeller impacts [42] for secondary nucleation are similar
to those developed later for those two mechanisms for microcarrier
culture by Cherry and Papoutsakis [27]. The details of these mod-
els are beyond the scope of this article but in essence they suggest
that ‘damage’ (whether destroying cells or just removing them from
microcarriers) is very sensitive to mean speciﬁc energy dissipation
rate.
For example, for microcarrier–impeller impacts [42] based on
a model related to the frequency of circulation of microcarriers
through the impeller zone, the kinetic energy of impact should
impact occur, and the probability of impact, the potential for dam-
age, DM-I is related to the agitation parameters by the functionality,
DM-I ∝ ε¯TN (4)
and  is proportional to particle concentration, X.
For  microcarrier–microcarrier impact on the other hand, the
model [41] is based on an energy cascade, starting with that put
in by the impeller causing both ﬂuid and particle motion. Of the
latter, part goes to overcoming ﬂuid drag, part to elastic deforma-
tion following impact and part to damage, DM-M. The latter is related
to agitation and other parameters by;
DM-M ∝ d6microcarrier ε¯1.5T X2 (5)
where  dmicrocarrrier is the diameter of the microcarrier. The equations
developed by Cherry and Papoutsakis [27] are very similar.
The  precise formulation of these equations is not important.
What is important is that the impaction mechanisms do not apply
to free suspension cells because they are too small to cause either
type of impact to occur. Secondly, the mechanism associated with
the Kolmogorov scale is only weakly dependent on speciﬁc power
(or relatively on agitator speed) since
K ∝ ε¯−1/4T ∝ N−3/4 (6)
whilst  the impact mechanisms are very sensitive to agitator speed.
Thus;
4DM−I ∝ N (7)
and
DM-M ∝ N4.5 (8)
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Thus, it should be possible to dramatically increase parameters
hich lead to cell detachment by increasing agitation intensity
speed) whilst at the same time keeping the Kolmogorov scale
reater than the cell size once it has been removed. Those ideas are
he fundamental ones behind this new method of cell detachment.
. Material and methods
.1.  Assessing live cells in relation to detachment efﬁciency
The  cells used in all studies were human bone-marrow derived
SCs which were obtained from Lonza (Lonza, Cologne AG) from
wo healthy donors after the patients provided informed consent.
he local Ethical Committee approved the use of the sample for
esearch. All studies were conducted with hMSCs at passage 3 for
oth primary cell lines, hereafter referred to as hMSC1 and hMSC2.
or further speciﬁc details of the T-ﬂask monolayer, spinner ﬂask
nd bioreactor culture conditions used for growing the cells, the
eader is directed to Raﬁq et al. [1]. Of particular importance for
his study is the bead and cell densities used in the stirred spinner
asks and bioreactor, which were 5000 beads/ml and 5 cells/bead
espectively, to give 6000 cells/cm2, approximately the same as in
he T-ﬂask. At conﬂuence, the maximum cell density expressed as
ells/cm2 was very similar in all conﬁgurations.
A critical element in assessing detachment is the ability to deter-
ine accurately the number of live cells on the microcarriers before
etachment is commenced; and then the numbers removed (or
ossibly still remaining on the microcarriers after detachment has
een tried). Ideally, all cells should be removed and all cells before
nd after removal should be viable. Here, viable cell number was
ssessed using the automated NucleoCounter NC-100 (Chemome-
ec, Denmark) which involved permeabilising the cell membrane
y adding Buffer A100 (Chemometec, Denmark) in an equal volume
o the cell sample. The sample was then mixed using a vortex mixer
or 30 s and then left to settle for 30 s to ensure that all cells were
xposed to the permeabilisation buffer. Buffer B (Chemometec,
enmark), a stabilisation buffer, was then added in equal volume
o that of Buffer A and similarly was mixed for 30 s and left to stand
or 30 s before running the sample. The NucleoCassette (Chemome-
ec, Denmark) was then used to withdraw the permeabilised cell
ample and run on the NucleoCounter NC-100. Nuclei released
ollowing cell permeabilisation are stained by propidium iodide
ontained within the NucleoCassette.
Initially, it was established that the number of live hMSCs
ttached to microcarriers could be accurately counted this way,
ased on the concept that since the cells would be permeabilised,
hey would release their nuclei into the cell suspension and could
hen be subsequently analysed. This ability to count cells whilst
till attached to microcarriers was investigated by taking samples
f cell–microcarrier cultures in spinner ﬂasks. After 4 days in
ulture in two separate 100 mL  spinner ﬂasks as described in
etail in our previous paper [1], four 2 mL  samples were collected
rom each ﬂask. For two of the samples, the number of cells still
ttached to the microcarriers was estimated as set out above
i.e. assuming that permeablisation had released the nuclei);
nd two samples after cell detachment from the Plastic P102-L
icrocarriers following the method described by Dos Santos et al.
13]. In summary, they took a small (0.5 mL)  microcarrier–cell
uspension sample from a spinner ﬂask and washed it with PBS
nd TrypLE Express. The suspension was then held at 37 ◦C for
–7 min  whilst agitating at 650 rpm using a temperature controlled
ample tube mixer, ThermoMixer comfort (Eppendorf, Germany).
ubsequently, medium was added to stop enzymatic activity and
he cells were ﬁltered from the microcarriers suspension, the cell
umber and viability being determined using the Trypan Blueeering Journal 85 (2014) 79–88
exclusion  method. Essentially, the same technique was  used here
except detachment was  achieved using trypsin-EDTA.
3.2. Detachment using the manufacturer’s protocol
The hMSC1 and hMSC2 cells were grown in duplicate in 100 mL
dimple-bottomed spinner ﬂasks at a working volume of 100 mL
(vessel height = 135 mm,  vessel diameter, T = 60 mm)  (BellCo, USA)
with a magnetic horizontal stir bar (length = 40 mm)  and a vertical
paddle (paddle diameter, D = 50 mm).  The horizontal stir bar was  set
to 5 mm above the dimple bottom of the spinner ﬂask and agitation
was achieved using a Bell-EnniumTM Compact 5 position magnetic
stirrer platform (BellCo, USA). With a 100 mL  working volume, the
height of the liquid in the vessel was 50 mm and agitation was set at
30 rpm (NJS), the speed assessed visually as being necessary to just
maintain all of the microcarriers fully in suspension. The spinner
ﬂask was  installed in a 37 ◦C, humidiﬁed incubator supplemented
with air containing 5% CO2.
The cells were then cultured for a period of 6 days, with a 50%
medium exchange after 72 h as described in detail in [1]. Microcar-
rier samples were then collected at day 6 and the number of cells
attached to the microcarrier was determined as described above
using the automated NucleoCounter NC-100.
A harvesting procedure suggested by the microcarrier manufac-
turer (SoloHill) was then applied. This method involved stopping
agitation and allowing the culture to settle. The medium was
then removed, ensuring that the settled microcarriers were not
disturbed. The microcarriers were then washed twice by adding
100 mL  of Ca2+ and Mg2+ free PBS and agitating the culture at 40 rpm
for 15 min  at 37 ◦C in the presence of 5% CO2. 30 mL of 0.25% (v/v)
trypsin and 0.02% (w/v) EDTA was then added to the spinner ﬂask
and allowed to incubate without agitation for 15 min  again at 37 ◦C
with 5% CO2. Though not directed by the manufacturer, it was con-
sidered important, as when detaching cells from T-ﬂasks, that after
the 15 min  incubation, the microcarrier–cell suspension contain-
ing trypsin and EDTA was diluted with 45 mL of growth medium to
minimise the impact of trypsin on the quality of the cells. Finally,
the cell suspension was  gently pipetted up and down to dislodge the
cells into a single cell suspension as directed by the manufacturer;
presumably to expose the cells to elongational shear stresses [43].
This suspension of cells was then centrifuged for 5 min  at 220 rpm
and resuspended in 20 mL  of growth medium and the number of
cells present was again assessed.
3.3. The new harvesting protocol for detachment followed by
separation  into a cell-only suspension
The new protocol was  developed for harvesting from a spinner
ﬂask based on the theory set out in Section 2.2. Here the detachment
principle as applied to the current ﬂasks is ﬁrst quantiﬁed and then
the precise experimental procedure is given.
As reported in [1], hMSC1 cells were successfully cultivated by
agitation at NJS (30 rpm) in the spinner ﬂask identiﬁed in Section
3.2. An estimation of the maximum speciﬁc energy dissipation rate
was obtained from [6] where the same spinner giving the same NJS
as here was used, gives εTmax = ∼9 × 10−4 W/kg. Thus, from Eq. (1),
K is ∼180 m,  a value as expected, well above the eddy size (sug-
gested from the work of Croughan et al. [29,30]) at which damage
should occur. For detachment, it was  then decided to signiﬁcantly
increase the speed for a short time to enhance detachment but keep
it less than that at which bubbles would be dragged into the suspen-
sion through the upper surface as damage due to stresses associated
with bubble disengagement through that surface can be extremely
damaging for animal cells [23]. Thus, a speed of 150 rpm and a time
of 7 min  were selected.
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Under these conditions, the ﬁve fold increase in impeller speed
ncreased the detachment mechanisms, DM-I and DM-M by factors
f ∼625 and ∼1400 respectively. However, once detachment was
omplete, whilst the value of εTmax increased to ∼0.11 W/kg, the
olmogorov scale was only reduced to 55 m,  well above the size
f the detached cells. Therefore, once detached, damage to the cells
hould not occur. It was decided to use this approach to try to
mprove the technique proposed by SoloHill [22].
The actual experimental programme enabled both the new pro-
ocol and the SoloHill one to be directly compared. The hMSC1 and
MSC2 cells were grown in four 100 mL  spinner ﬂasks at a working
olume of 100 mL  as set out in detail in [1] and as described in Sec-
ion 3.2. For detachment, initially samples were taken on day 6 to
scertain the viable cell number in each spinner ﬂask prior to har-
esting. Then, the technique also set out above was used to detach
he cells using in two of the ﬂasks the method proposed by Solo-
ill and in the other two using the new agitation strategy after the
rypsin-EDTA had been added. Thus, the microcarrier suspension
as agitated for 7 min  at 150 rpm. In addition, because in mono-
ayer culture, the tissue culture ﬂask is usually manually tapped to
id detachment after removal from the incubator, it was  decided to
ncrease the speed to 200 rpm for the ﬁnal 5 s. After agitation, the
ells were quenched with 70 mL  growth medium.
With  SoloHill’s detachment protocol, there was no effective sep-
ration step to generate a cell suspension free of microcarriers.
herefore, a new separation method needed to be developed too.
iven that the size of the cells and the microcarriers are so differ-
nt, it was felt that it would be appropriate to use vacuum ﬁltration.
or this step, therefore, the separation was achieved by using a
teriﬂip® 60 m ﬁltration unit (Millipore, UK) so that the cells and
uspending ﬂuid passed through and the microcarriers were ﬁl-
ered out. Even though aggregation of cells has been reported [5],
one were observed here and ﬁltration occurred in approximately
 min. Moreover, though there were concerns that an excessive
lter cake would form thereby restricting ﬂow, this problem did
ot occur. The cell suspension was then centrifuged at 220 g for
 min  and resuspended in growth medium. Cell number and via-
ility were then determined as described above. In addition to
hese experiments in which cells were both grown and detached
n spinner ﬂasks, as reported earlier [1], 60 mL  of the 5 L bioreac-
or culture (hMSC1 cells) was transferred to spinner ﬂasks and the
ame harvesting protocol was used.
Finally, another, 2.5 L culture as described in [1] was successfully
ndertaken in the 5 L bioreactor and a sample from the bioreactor
as analysed using the Nucleocounter. Then, 500 mL  were trans-
erred into 5 fresh spinner ﬂasks to perform the harvest, i.e. 100 mL
f the culture was placed into each spinner ﬂask. These 5 spinner
asks were then harvested independently using the new harvest-
ng protocol; and after harvesting the 100 mL  suspensions from the
 spinner ﬂasks were pooled.
Whilst  the harvesting has been performed in spinner ﬂasks, in
rinciple, as discussed later, the cell detachment step can be carried
ut in situ in the bioreactor without the need to transfer to spin-
er ﬂasks. However, it is still envisaged that the ﬁnal separation
f the cells from the microcarriers post-detachment to complete
arvesting would be undertaken outside of the bioreactor.
.4.  Cell characterisation
The  hMSC1 and hMSC2 cells were characterised in accordance
ith the International Society for Cellular Therapy (ISCT) criteria
hich states that greater than 95% of the cell population should
e positive for CD73, CD90 and CD105 and less than 2% positive
or CD14, CD19, CD34, CD45 HLA-DR. Moreover, the cells should
emonstrate the ability to adhere and grow as a monolayer on
issue culture plastic and retain the ability to differentiate downeering Journal 85 (2014) 79–88 83
the  adipogenic, osteogenic and chondrogenic lineages [44]. To
show these effects, the hMSCs post-harvest were analysed by ﬂow
cytometry for the aforementioned immunphenotypic markers as
explained in Raﬁq et al. [1]. Cells were also cultured in the respec-
tive differentiation media (all obtained from Life Technologies, UK)
for 21 days with differentiation medium exchanges every 72 h.
For cells undergoing adipogenic and osteogenic differentiation,
hMSCs were seeded onto microwell plates at a density of 5000
cells/cm2 and placed in a humidiﬁed incubator at 37 ◦C, 5% CO2.
For cells undergoing chondrogenic differentiation, a micromass of
hMSCs was generated by seeding 5 L of hMSC suspension at a
density of 1.6 × 107 cells/mL into a microwell plate. The microwell
plate was  placed into the incubator for 2 h, after which 1 mL  chon-
drogenic differentiation medium was added; the cells were then
returned to the incubator.
Staining  of the hMSCs differentiated towards the chrondrogenic
lineage involved ﬁxing the cells with 2% (v/v) paraformaldehyde
(PFA) for 30 min  at room temperature, cells were washed three
times with Ca2+ and Mg2+ free PBS. After this, a 1% (w/v) Alcian
Blue (chondrogenic) solution (Sigma Aldrich, UK) was  added to the
cells which were then incubated at room temperature for 60 min.
The samples were washed with PBS three times and 1 mL distilled
water was added. Upon ﬁnal washing, the samples were observed
under a Nikon TS-100 light microscope (Nikon, UK).
Staining of the hMSCs differentiated towards the osteogenic
lineage involved ﬁxing the cells with 10% cold neutral-buffered for-
malin for 20 min at room temperature. The cells were washed with
Ca2+ and Mg2+ free PBS and left in distilled water for 15 min  at room
temperature before incubating with 4% (v/v) Napthol AS-MX phos-
phate alkaline solution (Sigma–Aldrich, UK) in the dark at room
temperature for 45 min. The cells were washed three times with
distilled water, after which the samples were incubated with 2.5%
(v/v) silver nitrate solution (Sigma–Aldrich, UK) for 30 min  at room
temperature. The samples were then washed with distilled water
three times before observing under the Nikon light microscope
mentioned previously.
Cells  for differentiation controls were cultured and stained
under the same conditions and subject to the same medium
exchange routine, with the exception that the cells were cultured
with growth medium.
The  assessment was performed on cells prior to expansion on
the microcarriers and on the cells after harvesting. In addition, cells
obtained after harvesting were seeded into T-25 ﬂasks to determine
their ability to attach to tissue culture plastic as well as to qualita-
tively identify any morphological changes to the cells post-harvest
using a Nikon TS-100 light microscope (Nikon, UK).
4.  Results
4.1. Assessment of cell viability before and after detachment
To  determine whether we  could effectively ascertain cell viabil-
ity whilst the cells were still attached to the microcarrier, a study
was conducted where samples of cell–microcarrier suspensions
were detached according to the Dos Santos et al. [13] protocol
and counted. These cell count values were then compared with
values obtained when cells were not removed from the micro-
carrier using the Nucleocounter (as described in Section 3.1). In
spinner ﬂask 1, the cell density obtained was 1.48 × 105 cells/mL
after detaching the cells (again using the Dos Santos et al. method
[13]), whilst the value was  1.52 × 105 cells/mL after counting with
the cells still attached to the microcarrier (the Nucleocounter
method). The values for spinner ﬂask 2 were 1.36 × 105 cells/mL
and 1.28 × 105 cells/mL respectively. The difference between the
viable cell densities from these two  counting methods were not
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Fig. 1. Phase-contrast image of microcarrier and cell suspension after dissociation du
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rrow: hMSC still attached to the microcarrier
tatistically signiﬁcant as determined by the Bland–Altman anal-
sis (where differences on the Bland–Altman plot were deemed
nsigniﬁcant based on 95% limits of agreement). As such, the two
ethods can be considered comparable. Any difference was prob-
bly due to sample variations used for the analysis. Clearly, the
echnique was able to assess the number of live cells initially
ttached and then detached.
.2.  Detachment efﬁciency using the manufacturer’s protocol
Based  on the cell density obtained on the microcarriers at the
ime of sampling from the spinner ﬂask, there should have been
14.6 × 106 viable cells present. However after harvesting, only
.356 × 106 cells were obtained resulting in a harvesting efﬁciency
f less than 2.5%, based on the deﬁnition
efficiency (%) =
hactual
hexp ected
× 100 (9)
here  hefﬁciency is the harvesting efﬁciency (%), hactual is the number
f viable cells obtained after the harvesting protocol and hexpected
s the number of viable cells expected in the culture based on the
 mL  sample analysis of cells on microcarriers outlined above. That
fﬁciency is clearly unacceptable.
Two reasons for this low efﬁciency were considered possible.
irstly, cells may  not have been removed from the microcarriers;
nd secondly, the separation technique based on centrifugation
ay have been inefﬁcient. However, the latter worked well for the
etachment of cells from T-ﬂasks [21] and microscopic examina-
ion of the microcarriers after this treatment clearly showed that
ig. 2. Phase-contrast image of (A) fresh microcarriers with no cells attached and (B) micre manufacturer’s harvesting procedure for (A) hMSC1 and (B) hMSC2. Magniﬁcation
large  numbers of cells were still on them for both the hMSC1 and
hMSC2 cells (Fig. 1). To compare and contrast, Fig. 2 shows fresh
microcarriers, i.e. the expected appearance of microcarriers when
all the cells have been detached (Fig. 2A) and microcarriers during
cultivation with many cells attached (Fig. 2B). Clearly, an improved
detachment technique was required and the results from the one
developed here are presented next.
4.3. 4.3 Detachment efﬁciency comparing the manufacturer’s
protocol and the new one
As  in the initial study, the manufacturer’s protocol resulted
in a very low harvesting efﬁciency, this time 3.1% for hMSC1,
after only 0.443 × 106 (±9.5 × 104) cells (mean value ± SD,  n = 4)
were successfully harvested from the microcarriers from an
expected number of 14.3 × 106 (±8.5 × 105) cells (mean value ± SD,
n = 4). The new approach, on the other hand, resulted in > 95%
harvesting efﬁciency, with 14.5 × 106 (±3.5 × 105) cells (mean
value ± SD, n = 4) successfully harvested from an expected num-
ber of 15.2 × 106 (±6.5 × 105) cells (mean value ± SD, n = 4). In both
cases (harvest using the manufacturer’s and the novel procedure),
the cell viability of the harvested cells was  greater than 98%.
Likewise  for hMSC2, from an expected number of 15.4 × 106
(±6.6 × 105) cells (mean value ± SD, n = 4), only 0.752 × 106
(± 5.9 × 104) cells (mean value ± SD, n = 4) were harvested using
the manufacturer’s protocol, a harvesting efﬁciency of 4.9%. In
comparison, the new harvesting procedure again resulted in >95%
harvesting efﬁciency where 14.2 × 106 (±6.2 × 105) cells (mean
value ± SD, n = 4) were successfully harvested from 14.6 × 106
ocarriers with many hMSCs attached as indicated by the arrows. Magniﬁcation 10x.
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F during the novel harvesting procedure for (A) hMSC1 and (B) hMSC2. Magniﬁcation 10x.
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Table 1
Immunophenotype of hMSC1 and hMSC2 after novel harvest procedure (mean
value  ± SD, n = 4).
Surface marker hMSC1
Percentage
expression
hMSC2
Percentage
expression
CD73 98.3 ± 0.4 99.1 ± 0.6
CD90  99.2 ± 0.4 98.9 ± 0.3
CD105  98.5 ± 0.3 99.5 ± 0.4
CD14  0.19 ± 0.03 0.33 ± 0.2
CD19  0.89 ± 0.12 0.66 ± 0.15
CD34  1.1 ± 0.4 1.5 ± 0.3ig. 3. Phase-contrast image of microcarrier and cell suspension after dissociation 
rrows: (1) Single hMSC successfully detached from microcarrier, (2) hMSCs still at
±4.8 × 105) cells (mean value ± SD, n = 4). Clearly, the new har-
esting procedure was  signiﬁcantly better than that based on
he manufacturer’s protocol, and could be considered a success.
imilar results were obtained for the harvesting of samples taken
rom the bioreactor as described in Raﬁq et al. [1].
The  stark difference in the number of cells successfully har-
ested for both the hMSC1 and hMSC2 cells is clearly as a result
f the agitation during trypsinisation, as illustrated in Fig. 3, which
hows the microcarrier and cell suspension immediately after
uenching with growth medium. Comparing this with Fig. 1 from
he original study at the same point in the process, it is clear that
he majority of the cells have been successfully harvested from the
icrocarriers with the new protocol whilst with the manufacturer’s
rocedure, very few of the cells detached.
For the culture done in the bioreactor, the manufacturer’s
rotocol was not applied. However, the analysis using the Nucleo-
ounter indicated that the total viable cell number in the 2.5 L was
175 × 106 cells whilst in the 500 mL  pooled from the 5 spinner
asks, the number of cells present was ∼35 × 106 cells, approxi-
ately one ﬁfth of those present in the 2.5 L. Clearly, the whole
rocedure led to some small experimental error but essentially
t showed that with the new technique ∼ 100% of the cells were
etached in each of the 5 spinner ﬂasks.
.4. Cell characterisation
After  harvesting the hMSCs via both techniques, the intention
as to characterise the cells in accordance with the ISCT guide-
ines to ascertain whether the harvesting procedure affected the
uality of the cells. However as so few cells were obtained from
anufacturer’s harvesting procedure, it was not possible to per-
orm all the characterisation techniques, and instead the hMSC1
nd hMSC2 harvested cells were only characterised by inoculating
 tissue culture ﬂask with these cells to determine if they attached
nd formed a monolayer culture. Fig. 4A andB depicts the hMSC1
nd hMSC2 cells respectively after they had been harvested via the
anufacturer’s protocol.
All  characterisation analyses were performed on the cells
btained by the new procedure after ﬁltration from the microcar-
iers whether they were grown initially in the spinner ﬂasks or in
he bioreactor. Table 1 demonstrates that the harvesting procedure
ad no effect on either the hMSC1 or hMSC2 immunophenotype
ased on the ISCT guidelines, with greater than 98% of the cellsCD45  1.4 ± 0.5 0.80 ± 0.32
HLA-DR  0.85 ± 0.08 1.77 ± 0.12
expressing CD73, CD90 and CD105, and less than 2% of the cells
expressing CD14, CD19, CD34, CD45 and HLA-DR. Fig. 4C and D
illustrates the monolayer culture of the hMSC1 and hMSC2 cells
after harvesting with the novel procedure, thereby demonstrating
the retention of the cells’ ability to attach and proliferate on tissue
culture plastic, whilst exhibiting the same ﬁbroblastic, spindle-
shaped morphology expected of hMSCs [45]. Furthermore, the cells
stained positively for Alkaline Phosphatase and Von Kossa stain-
ing (Fig. 5A) demonstrating osteogenic differentiation, whereas the
control did not stain at all (Fig. 5D). The cells formed visible lipid
vacuoles in the cell cytoplasm typical of adipogenic differentiation
(Fig. 5B), however these were not observed in the adipogenic con-
trol (Fig. 5E). With respect to the chondrogenic differentiation, the
Alcian Blue staining illustrated in Fig. 5C stained the proteogly-
cans in the extracellular matrix. Micromass cultures were initiated,
but during medium changes, the micromasses became dislodged.
Nevertheless, the extracellular matrix clearly did still stain. In com-
parison, the chondrogenic control did not stain positive for Alcian
Blue staining, even in the cells’ extracellular matrix (Fig. 5F). These
quantitative and qualitative assays fulﬁl the ISCT criteria, which
include the expression/non-expression of cell surface markers,
plastic adherence and the ability to differentiate toward the mes-
enchymal lineages. As such it can be stated that the novel harvesting
procedure did not have any effect on hMSC quality.5. Discussion
The main advantage of the new detachment protocol is that
there is a very high harvesting efﬁciency and the exposure time of
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Fig. 4. Monolayer culture after harvesting for (A) hMSC1 using manufacturer’s protocol, (B) hMSC1 using novel procedure, (C) hMSC2 using manufacturer’s protocol and (D)
hMSC2  using novel procedure. Magniﬁcation 10×.
Fig. 5. Phase-contrast images of hMSCs harvested from the Plastic P102-L microcarriers using the novel harvesting procedure demonstrating differentiation potential down
the  (A) osteogenic, (B) adipogenic and (C) chondrogenic lineages. Control images for (D) osteogenic, (E) adipogenic and (F) chondrogenic differentiation. Magniﬁcation 10×.
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he hMSCs to trypsin is greatly reduced. It is widely acknowledged
hat trypsin can cause cell damage, particularly if cells are exposed
o trypsin for long periods [46], and with respect to hMSCs speciﬁ-
ally, CD105 expression decreased with trypsin exposure time over
 range of 5, 30 and 90 min  [18]. On the other hand, Frauenschuh
t al. [3] and Schop et al. [47] each developed a harvesting pro-
edure, which required exposure to trypsin for over 1 h, and still
eported that hMSCs maintained their immunophenotype and mul-
ipotency. Overall, the reduction to the precise time used in the new
rotocol may  not be critical but keeping this time short is clearly
dvantageous.
On the other hand, exposure to the high agitation speeds
nvolved might have been expected to damage cell quality
ttributes (cell immunophenotype or multipotency). That, how-
ver, is not the case. Here, it is proposed that the lack of damage is
ecause once the cells are detached they are smaller than the Kol-
ogorov scale based on εTmax estimated from the swept volume as
xplained above.
As  pointed out above and emphasised in the recent review by
hen et al. [15], there has been very little focus on harvesting from
hose studies investigating the expansion of hMSCs on microcarri-
rs. In many cases, it is difﬁcult to ascertain whether the cultures
ere completely harvested, or whether the detachment of cells
ccurred only for small samples (usually in the range of a few
L). Yang et al. [8] appear to be the ﬁrst to focus primarily on
etachment and harvesting, with the focus on shifting away from
rypsin to a thermoresponsive microcarrier which allows for the
etachment of cells with a change in temperature. In principle,
uch a concept is promising. However, there are number of issues
o consider. Firstly, the need to coat the microcarrier with the ther-
oresponsive substrate may  affect the ease with which cells attach.
lso, if a speciﬁc microcarrier was chosen for its coating or surface
roperties with respect to growth, the need to coat the microcar-
ier with another substrate would render the original properties
nusable and therefore ineffective. Finally, the process of coating
he microcarriers may  itself be difﬁcult to scale-up.
.1. Scale-up considerations and sensitivity analysis of
etachment
For  scale-up of detachment, it seems quite feasible to build on
he current approach. For both of the impaction mechanisms (Eqs.
4) and (5)), the mean speciﬁc energy dissipation rate, ε¯T , is a major
actor. Based on this criterion, a similar performance should be
xpected on scale-up if it is held constant. For example, for treating
he 2.5 L cell–microcarrier suspension in the 5 L stirred bioreac-
or, ideally the same ε¯T should be used as in the spinner ﬂask,
amely 0.079 W/kg. Therefore, with its down pumping 3-blade
5◦-pitch deep-blade impeller of diameter, 70 mm (D/T = ∼0.44)
o give the same ε¯T (assuming a power number of 1.5 [48,49],
 speed of 120 rpm would be required. Since the speed is little
ower than in the spinner ﬂask, if the dominant detachment mech-
nism is impeller impact, the time would be 1–2 min  longer which
s still short compared to other traditional methods. If the dom-
nant mechanism is microcarrier–microcarrier impact, then the
ime should not change.
It  is also useful to conﬁrm that the Kolmogorov scale at this
ntensity of agitation in the 5 L bioreactor should not be a cause
or concern. Zhou and Kresta [34] give a  ˚ value of 15–20 for both
high’ and ‘low’ shear impellers of D/T = 0.5, so a value of 30 seems a
afe assumption for a D/T ratio of 0.44. In this case, εTmax would be
.34 W/kg and the Kolmogorov scale would be 26 m,  still above
he size of the cells. This D/T ratio is a sensible one to use on scale-up
s it minimizes the mean speciﬁc energy dissipation rate required
o suspend microcarriers [50] and therefore the chance of damage
uring culture.eering Journal 85 (2014) 79–88 87
The microcarrier concentration used in this study was  based
on a preliminary assessment of its impact on the culture of these
cells in spinner ﬂasks [21] and our earlier work [6] with other
MSCs. There, it was found that both higher and lower micro-
carrier concentrations gave lower MSC  cell densities. With this
microcarrier concentration, the cells grew to conﬂuence, which
limited the cell density achieved. Clearly, if the microcarrier con-
centration can be increased to give higher the cell densities in
the bioreactors, that would be beneﬁcial. Therefore an assessment
of the impact of such a change on this detachment technique is
valuable. Eq. (4) for microcarrier–impeller impacts indicates that
mechanism increases with microcarrier concentration; whilst. Eq.
(5) for microcarrier–microcarrier impacts shows that mechanism
increases with the square of the concentration. Thus, the time
required for detachment should remain the same or may  actually
decrease under these conditions.
5.2. Improvement and scale-up of separation
Though the harvesting efﬁciency using the new protocol was
>95%, there is reason to believe that this efﬁciency can increase
further especially for the separation step. It was  noticed that
whilst ﬁltering the cells from the microcarriers using the Steriﬂip®
vacuum ﬁltration device, the cake (the growing deposit of micro-
carriers) started to act as another ﬁlter and entrapped cells on it and
within it too. The use of a larger surface area of ﬁlter could reduce
this tendency. For a further increase in scale, larger ﬁlters would be
required and there may  be a limitation to the volume of suspen-
sion that can be handled that way. Certainly, the ﬁltering time will
increase which may  be an issue. Alternatively, a volume reduction
step could be employed following cell detachment; indeed large-
scale devices are now emerging on the market which appear to be
suitable for this function, for example the kSep® centrifuge pro-
vides a scalable device for the concentration, washing and harvest
clariﬁcation of up to 1000 L of culture broth [51].
6.  Conclusions
There is little focus on harvesting in those studies reported in the
literature investigating the expansion of hMSCs on microcarriers.
In many cases, it is difﬁcult to ascertain whether the cultures were
completely harvested, or whether the detachment of cells occurred
only for small samples (usually in the range of a few mL). Here, the
protocol outlined has enabled MSCs from two different donors to be
detached from SoloHill plastic microcarriers by using a short expo-
sure to trypsin whilst providing an intense level of agitation. On the
other hand, the protocol suggested by SoloHill [21] was unsatisfac-
tory and both it and the use of thermoresponsive microcarriers [8]
would be difﬁcult to scale-up.
The  approach seems well suited to scale-up with the mean spe-
ciﬁc energy dissipation rate required being very easily achieved
at any scale; and because of the proposed mechanisms of detach-
ment, it should be achieved in a short time. Also, once detached,
Kolmogorov’s theory suggests that, independent of scale, the cells
would not be damaged as they are smaller than the Kolmogorov
microscale. Once detached from the microcarriers, cell separation
by simple vacuum ﬁltration is also effective and again offers distinct
scale-up potential. As applied here, the harvesting efﬁciency was
>95% and cells after harvesting showed all the attributes expected
of hMSC cells. The overall protocol is also sufﬁciently ﬂexible that
it should be capable of being adapted to meet the problem of cell
line speciﬁcity. It might also meet the problem of cell/microcarrier
speciﬁcity too, adjusting the agitation and the time for its applica-
tion as well as the enzyme and its concentration to accommodate
how tightly different cells bind to different microcarriers.
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Indeed, this work suggests that for studies related to scale-up for
llogeneic therapeutic purposes, it is very important that cells and
icrocarriers are considered not only with respect to attachment
nd growth but also with detachment in mind; and the potential for
cale-up of the whole process because good attachment and growth
ithout efﬁcient detachment is not a viable large scale process.
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